Jon Cuthbert

Daiichi Sankyo and AstraZeneca (NYSE:AZN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending marketing authorization for Datroway (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple-negative breast cancer who are not candidates for PD-1/PD-L1 inhibitor therapy.

Italy’s antitrust authority said it has opened an investigation into Microsoft (NASDAQ:MSFT) over alleged unfair commercial practices linked to price changes in Microsoft 365 subscriptions.

Bitcoin (CRYPTO:BTC) and Ether (CRYPTO:ETH) are facing the expiry of about US$11 billion in options contracts.

Solana (CRYPTO:SOL) has fallen about 20% over the past month, although on-chain activity has continued to grow as trading volumes increase across decentralised applications.

ASIC has filed Federal Court proceedings against former directors and compliance committee members of Keystone Asset Management Ltd (Receivers & Managers Appointed) (In Liquidation) over alleged failures in the management of the Shield Master Fund, which held more than A$530 million from around 5,800 superannuation investors.

Russia has introduced an experimental legal regime allowing selected exporters and importers to use cryptocurrency for cross-border trade settlements.

Recce Pharmaceuticals (ASX:RCE) has secured firm commitments to raise $4 million through a new institutional share placement.

Kanga Exchange EU, operated by SIA AlphaRoute, has received a Class 3 Markets in Crypto-Assets (MiCA) licence from the Bank of Latvia.

American Bitcoin approved a one-for-15 reverse stock split after shareholders voted in favour of several corporate proposals at the company's 2026 annual meeting.

NRW Holdings (ASX:NWH) announced that its subsidiary Golding Contractors has secured two contracts worth up to $195 million.